Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 1:40 AM
NCT ID:
NCT01110694
Eligibility Criteria:
Inclusion Criteria:
* Individuals over the age of 18 with a diagnosis of definite or probable IPF or definite or probable fibrotic NSIP as defined by the ATS/ERS consensus classification
Exclusion Criteria:
* Patients with co-existent conditions known to be associated with the development of fibrotic lung disease will be excluded.
* This includes
* connective tissue disease
* suspected drug-induced lung disease
* asbestosis or other asbestos related disease (pleural plaques, mesothelioma, asbestos pleural effusions)
* granulomatous disease including sarcoidosis.
* Patients with an auto-immune profile considered diagnostic for a specific connective tissue disease will be excluded, even in the absence of systemic symptoms.
* Non-specific rises in auto antibodies e.g. rheumatoid factor, anti-nuclear antibody etc. will not be used to exclude individuals from the study.
* Patients with co-morbid disease that in the opinion of the investigators gives them an expected life expectancy of less than one year will be excluded from the study.
* Patients involved in clinical trials assessing novel IPF therapies will be excluded from enrolment in this study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01110694
Study Brief:
Protocol Section:
NCT01110694